Therefore, in the present study, we developed a novel enzyme-linked immunosorbent assay (ELISA) system for detecting perioperative plasma GPC3 levels and evaluated the usefulness of GPC3 as a predictor for recurrence after surgical resection, particularly in patients with stage I HCC. The gene discussed is GPC3; the disease is hepatocellular carcinoma.